A Study of SPY072 in Rheumatic Disease
Phase 2
285
about 2.6 years
18+
13 sites in AZ, CA, FL +2
About this study
This trial is testing a treatment called SPY072 compared to a placebo in adults with rheumatic diseases. The goal is to see if SPY072 is effective and safe for this condition.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Placebo
- 2.Take SPY002-072
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Axial Spondyloarthritis: Change from baseline in Ankylosing Spondylitis Disease Activity Score (ADAS), Rheumatoid Arthritis: Change from baseline in Disease Activity Score in 28 joints (c-reactive protein) (DAS-CRP)
Secondary: Psoriatic Arthritis: Change from baseline in Disease Activity Index for Psoriatic Arthritis (DAPSA)
Dermatology, Immune, Musculoskeletal